| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
7,118 |
6,358 |
$373K |
| S0302 |
Completed early periodic screening diagnosis and treatment (epsdt) service (list in addition to code for appropriate evaluation and management service) |
5,218 |
5,108 |
$255K |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
3,287 |
3,202 |
$69K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
572 |
533 |
$34K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
401 |
387 |
$23K |
| 90461 |
|
742 |
729 |
$19K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
227 |
211 |
$17K |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
105 |
100 |
$14K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
381 |
369 |
$14K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
400 |
386 |
$14K |
| 92551 |
|
1,891 |
1,840 |
$12K |
| 99188 |
|
1,131 |
1,111 |
$9K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
864 |
818 |
$8K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
104 |
103 |
$6K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
75 |
73 |
$4K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
369 |
360 |
$4K |
| 87070 |
|
625 |
594 |
$3K |
| 99173 |
|
2,268 |
2,134 |
$3K |
| 90686 |
|
912 |
897 |
$1K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
13 |
13 |
$1K |
| 99000 |
|
48 |
33 |
$1K |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
43 |
36 |
$1K |
| 96127 |
|
274 |
267 |
$1K |
| 90473 |
|
78 |
76 |
$936.79 |
| 90480 |
|
15 |
15 |
$601.62 |
| 0001A |
|
13 |
13 |
$561.08 |
| 90672 |
|
320 |
314 |
$543.86 |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
29 |
23 |
$500.12 |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
12 |
12 |
$415.68 |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
72 |
53 |
$378.45 |
| 99177 |
|
59 |
59 |
$127.95 |
| 36416 |
|
76 |
68 |
$121.06 |
| 90656 |
|
12 |
12 |
$24.12 |
| 90688 |
|
26 |
25 |
$19.09 |
| 90698 |
|
40 |
38 |
$0.00 |
| X5622 |
|
1,567 |
1,522 |
$0.00 |
| 96160 |
|
1,211 |
1,179 |
$0.00 |
| 90670 |
|
40 |
39 |
$0.00 |
| 90633 |
|
31 |
26 |
$0.00 |
| 90685 |
|
33 |
33 |
$0.00 |